Vous êtes ici : Accueil > ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition.

Publications IRCM

ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition.

Publié le 26 octobre 2023
ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition.
Description
 
Date 
Auteurs
Bakhos-Douaihy D, Desmaze C, Jeitany M, Gauthier LR, Biard D, Junier MP, Chneiweiss H, Boussin FD
Revue
Année
2019
Service
IRCM/SCSR
Institut
IRCM
Laboratoire
IRCM/SCSR/LRP
Résumé
 
Date de création31/12/2019

Go back to list